How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections - Kassamali, Zahra; Danziger, Larry H.; Glowacki, Robert C.; Schwartz, David N. (International journal of infectious diseases, 2013)
Keywords: Adult; adults; Aged; Aged, 80 and over; amphotericin B; Amphotericin B - administration & dosage; Amphotericin B - adverse effects; Antifungal Agents - administration & dosage; Antifungal Agents - adverse effects; Antifungal pharmacology; Candida; Female; Fungal infections; fungi; Hospitalization; Humans; hypokalemia; Infectious Disease; Liposomal amphotericin B; Liposomes; Male; Middle Aged; Mycoses - drug therapy; Mycoses - mortality; nephrotoxicity; pathogens; patients; Pulmonary/Respiratory; Retrospective Studies; statistics; Treatment Outcome; Young Adult; Antifungal pharmacology; Liposomal amphotericin B; Fungal infections